Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma

Purpose: This is a first-in-man safety study in locally advanced pancreatic cancer (LAPC) using a targeted intra-arterial delivery catheter (RenovoCath™). Methods: Twenty patients were enrolled in a four-stage dose escalation of intra-arterial, locally delivered gemcitabine, at doses up to 1000 mg/m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosemurgy, Alexander S., Ross, Sharona B., Vitulli, Paul L., Malek, Reza, Li, Jaili, Agah, Ramtin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933492/
https://www.ncbi.nlm.nih.gov/pubmed/30631844
http://dx.doi.org/10.1089/pancan.2017.0011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933492/
https://www.ncbi.nlm.nih.gov/pubmed/30631844
http://dx.doi.org/10.1089/pancan.2017.0011

Ejemplares similares